LalwaniA.K., SooyC.D.Otologic and neurologic manifestations of acquired immunodeficiency syndrome. The Otolaryngological Clinics of North America1992; 25(6): 1183–1198.
2.
RealR., ThomasM., GerwinsJ.M.Sudden hearing loss and acquired immunodeficiency syndrome. Otolaryngology Head and Neck Surgery1987; 97: 4099–412.
3.
SooyC.D.Impact of AIDS on Otolaryngology Head and Neck Surgery. In MyersE.N. (ed): Advances in Otolaryngology-Head and Neck Surgery, vol 1, Chicago, 1987, Year Book Medical Publishers, 1–27.
4.
TimonC.I., WalshM.A.Sudden hearing loss as a presentation of HIV infection. Journal of Laryngology and Otology1989; 103: 1071–1072.
5.
HartC.W., CokelyC.G., SchupbachJ., Dal CantoM.C., CopplesonL.W.Neuro-otologic findings of a patient with AIDS. Ear and Hearing1990; 10: 68–76.
6.
SchindlerL.W.“Understanding the Immune System”. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1990, NIH Publication NO. 88–529.
7.
RareyK.E.Otologic pathophysiology in patients with human immunodeficiency virus. American Journal of Otolaryngology1990; 11: 366–369.
8.
WilsonW.R.The relationship of the herpes virus family to sudden hearing loss: a prospective clinical study and literature review. Laryngoscope1986; 96: 870–877.
9.
GhermanC.R., WardR.R., BassisM.L.Pneumocystis carinii otitis media and mastoiditis as the initial manifestation of the acquired immunodeficiency syndrome. American Journal of Medicine1988; 85: 250–252.
10.
KohanD., HammerschlagP.E., HollidayR.A.Otologic disease in AIDS patients: CT correlation. Laryngoscope1990; 100: 1326–1330.
11.
SchinellaR.A., BredaS.D., HammerschlagP.E.(1987). Otic infection due to Pneumocystis carinii in an apparently healthy man with antibody to the human imuunodeficiency virus. Annals of Internal Medicine1987; 106: 399–400.
12.
FrickO.L.Role of viral infections in asthma and allergy. Clinical Review in Allergy1983; 1: 5–17.
13.
LanserM.J., KleinZ.H., MarvinA.Kaposi's sarcoma in patients with AIDS. Archives of Otolaryngology1985; 111: 486–489.
14.
BergstromL., ThompsonP.L.Ototoxicity. In: NorthernJL (Ed), Hearing Disorders, 1984, Austin, Little Brown and Co: 119–134.
15.
CowleyG., HagerM., MarshallR.AIDS: The next ten years. Newsweek1990–1; June 25.
JohnsonA.H., HamiltonC.H.Kanamycin ototoxicity-possible potentiation by other drugs. Southern Medical Journal1970; 63: 511.
18.
KabinsS.A.Interactions among antibiotics and other drugs. JAMA1972; 219: 206.
19.
BellA.F., AtkinsJ.S., ZajacR.Sensorineural hearing loss in AIDS (abstract). In Proceedings: Fourth International Conference on AIDS, Stockholm, 1988; 380, June 12–16.
20.
JacobsonJ.T.The Auditory Brainstem Response (eds), San Diego, 1985, College-Hill Press.
21.
BrackmanD.E., SeltersW.A.Electrocochleography in Meniere's disease and acoustic neuromas. In: RubenRJ, ElberlingC., SalomonG. (eds), Electrocochleography, Baltimore, 1976, University Park Press: 315–329.
22.
dentinsJ.D., McGeeT.Brainstem electric response audiometry in the differential diagnosis of acoustic tumors. Laryngoscope1979; 89: 31–42.
23.
CleminsJ.D., MitchellC.Electrocochleography and brainstem responses used in the diagnosis of acoustic tumors. Journal of Otolaryngology1977; 6: 447–458.
24.
DalyD.M., RoeserR.J., AungM.H., DalyD.D.Early evoked potentials in patients with acoustic neuroma. Electroencephalography and Clinical Neurophysiology1997; 43: 151–159.
25.
HallJ.W.Handbook of Auditory Evoked Responses.Allyn and Bacon, Boston, 1992.
26.
RosenhamerH.J.Observation on electric brainstem responses in retrocochlear hearing loss: a preliminary report. Scandinavian Audiology1977; 6: 179–196.
27.
TerkildsenK., OsterhannelP., Huis in't VeldF.Recording procedures for brainstem potentials. In: NauntonR.F., and FernandezC., (Eds), Evoked electrical activity in auditory nervous system.New York: Academic Press, 1977.
28.
ThomsenJ., TerkildsenK., OsterhammelP.Auditory brainstem responses in patients with acoustic neuroma. Scandinavian Audiology1978; 7: 179–183.
29.
HandelsmanL., HorvathT., AronsonM.Auditory event-related potentials in HIV-I infection: a study in the drug-user risk group. Journal of Neuropsychiatry and Clinical Neuroscience1992; 4: 294–302.
30.
IraguiV.J., KalmijnJ., ThalL.J., GrantI. & the HNRC Group. Neurological dysfunction in asymptomatic HIV-1 infected men: evidence from evoked potentials, Electroencephalography and clinical Neurophysiology1994; 92: 1–10.
31.
JabbariB., CoatsM., SalazarA., MartinA.Longitudinal study of EEG and evoked potentials in neurologically asymptomatic HIV infected subjects. Electroencephalography and clinical Neurophysiology1993; 86: 145–151.
32.
RagazzoniA., GrippoA., GhidiniP.Electrophysio-logical study of neurologically asymptomatic HIV-1 seropositive patients. Acta Neurologica Scandanavia1993; 87: 47–51.
33.
BirchallM., WightR., FrenchP.Auditory function in patients infected with the human immunodeficiency virus. Clinical Otolaryngology1992; 17: 117–121.
34.
Helweg-LarsenS., JacobsonJ.Myelopathy in AIDS. A clinical and electrophysiological study of 23 Danish patients. Acta Neurological Scandinavia1988; 77(1): 64–73.
35.
LiptonR.B., KruppL., HoroupianD.Progressive multifocal leukoencephalopathy of the posterior fossa in AIDS patients: clinical, radiographic and evoked potential findings. European Neurology1988; 28(5): 258–261.
36.
PaganoM.A., CahnP.E., GarauM.L.Brain-stem auditory evoked potentials in human immunodeficiency virus-seropositive patients with and without acquired immunodeficiency syndrome. Archives of Neurology1992; 49: 166–169.
37.
KeithR.SCAN: A Screening Test for Auditory Processing Disorders.San Antonio, Tx., The Psychological Corporation, Harcourt Brace Jovanovich, 1986.
38.
WelkoborskyH., LowitzschK.Auditory brain stem responses in patients with human immunotropic virus infection of different stages. Ear and Hearing1992; 13: 55–57.
39.
AntonelliA.R., BonfioliR.F., CappielloJ.Auditory evoked potential test battery related to magnetic resonance imaging for multiple sclerosis patients. Scandinavian Audiology1988; 30(Suppl.): 191–196.
40.
AndersK., GuerraW.F., TomiyasuU.The neuropathology of AIDS. UCLA experience and review. American Journal of Pathology1986; 124: 537–558.
41.
FalloonJ., EddyJ., WienerL.Human immunodeficiency virus infection in children. Journal of Pediatrics1989; 144: 1–30.
42.
RostadS.W., SumiS.M., ShawC.M.Human immunodeficiency virus (HIV) infection in brains with AIDS-related leukoencephalopathy. AIDS Research and Human Retroviruses1987; 3: 363–373.
43.
FrankY., VishnubhakatS., PahwaS.Brainstem auditory evoked responses in infants and children with AIDS. Pediatric Neurology1992; 8: 262–266.
44.
FrankY., PahwaS.Serial brainstem auditory evoked responses in infants and children with AIDS. Clinical Electroencephalography1993; 24(4): 160–164.
45.
BankaitisA.E.The effects of click rate on the auditory brainstem response (ABR) in patients with varying degrees of HIV-infection: a pilot study. Presented at the American Academy of Audiology National Convention, Richmond, Virginia. Accepted for future publication in Ear and Hearing, 1994–1995.
46.
FordJ.M., MohsR.C., PfefferbaumA.On the utility on P3 latency and RT for studying cognitive processes. Progressive Brain Research1980; 54: 661–668.
47.
HombergV., HefterH., GranseyerG.Event-related potentials in patients with Hunington disease and relatives at risk in relation to detailed psychometry. Electroencephalography and Clinical Neurophysiology1986; 63: 522–569.
48.
SquiresK.C., DonchinB., HemingR.On the influence of task relevance and stimulus probability on ERP components. Electroencephalography and Clinical Neurophysiology1977; 42: 1–14.
49.
PolichJ., LadishC.Bloom, FE. P300 assessment of early Alzheimer's disease. Electroencephalography and Clinical Neurophysiology1990; 77: 179–189.
50.
St. ClairD.M., BlackwoodD.H.R., ChristieJ.E.P300 and other long latency auditory evoked potentials in presenile demetia Alzheimer type and alcoholic Korsakoff syndrome. British Journal of Psychiatry1985; 147: 702–706.
51.
GrotmeyerK.H., HusstedtW., BrundermannH.Event-related potentials in HIV-infected outpatients. Aids Research and Human Retroviruses1991; 7: 629–635.
52.
OlloC., JohnsonR., GrafmanJ.Signs of cognitive change in HIV disease: An event-related brain potential study. Neurology1991; 41: 209–215.
53.
SyndulkoK., CohenS.N., Pettler-JenningsP.P300 and neurocognative function in neurologic patients. In: NodarR.H., & BarberC. (eds.), Evoked Potentials II: The Second International Evoked Potentials Symposium, 1984, (pp. 441–445), Boston, Butterworth.
54.
KeithR.SCAN-A: Screening Test for Auditory Processing Disorders for Adolescents and Adults.San Antonio, TX, The Psychological Corporation, Harcourt Brace Jovanovich, 1994.
55.
KeithR.W., GrantG.Standardization of SCAN-A: A test for auditory processing disorders in adolescents and adults. Presentation to the American Acadmey of Audiology Annual Convention, Pheonix, AZ, 1993, April.
56.
KeithR., PensakM.Central Auditory Function. The Otolaryngologic Clinics of North America1991; 24: 371–379.
57.
BergmanM., HirschS., SolziP., MankowitzZ.The threshold-of-interference tests: A new test of interhemispheric suppression in brain injury. Ear and Hearing1987; 8: 147.
58.
IvyR.M., BredesenControversies in HIV-related central nervous system disease: neuropsychological aspects of HIV-1 infection. In: VolberdinP., JacobsonM.A. (eds). AIDS clinical review, New York: Marcel Dekker1989; 153–191.
59.
PriceR.W., BrewB., SidtisJ.The brain in AIDS: central nervous system HIV-I infection and AIDS dementia complex. Science1988; 239: 586–592.
60.
WillefordJ.A., BurleighJ.M.Handbook of Central Auditory Processing Disorders in Children.Orlando, Grune & Stratton Inc., 1985.